Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP30 | Q70CQ3 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.41 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.41 |
| ▸ | CDK9 | P50750 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | JAK1 | P23458 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21871866 | 0.93 | HPGD (0.47) | USP30HPGDRECQLEPHX1ALDH1A1 | |
| SCHEMBL18609897 | 0.93 | HPGD (0.47) | USP30HPGDRECQLEPHX1ALDH1A1 | |
| SCHEMBL16365614 | 0.93 | USP30 (0.46) | USP30HPGDPIK3CDRECQLEPHX1 | |
| SCHEMBL31208882 | 0.93 | USP30 (0.46) | USP30HPGDPIK3CDRECQLEPHX1 | |
| SCHEMBL31085625 | 0.92 | HPGD (0.44) | USP30HPGDPIK3CDRECQLEPHX1 | |
| SCHEMBL316685 | 0.87 | HPGD (0.50) | USP30HPGDPIK3CDRECQLEPHX1 | |
| SCHEMBL316684 | 0.87 | HPGD (0.50) | USP30HPGDPIK3CDRECQLEPHX1 | |
| SCHEMBL84791 | 0.87 | HPGD (0.50) | USP30HPGDPIK3CDRECQLEPHX1 | |
| SCHEMBL7811814 | 0.84 | NR1H2 (0.43) | USP30HPGDPIK3CDRECQLEPHX1 | |
| SCHEMBL12526367 | 0.84 | HPGD (0.49) | HPGDRECQLEPHX1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240368193-A1 | KRAS INHIBITORS | ELI LILLY AND COMPANY | 2024-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368193-A1 | KRAS INHIBITORS | KRAS, NRAS, HRAS | USP30 2132/4885HPGD 2249/4885PIK3CD 588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.